TOLERIS
Live / Applied — First extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 08 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98440237
- Mark type
- Stylized text
- Filed
- 08 Mar 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 005 — Pharmaceuticals: A house mark for a pharmaceutical preparation for the prevention of autoimmune diseases and disorders; a house mark for a pharmaceutical preparation for the treatment of autoimmune diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; biomedical research services; pharmaceutical drug development services
Owner
- TOLERIS BIOTHERAPEUTICS GMBH, WUERZBURG, DE
- TOLERIS BIOTHERAPEUTICS GMBH, WUERZBURG, DE
- Julius-Maximilians-Universität Würzburg, Würzburg, DE
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 1 GRANTED
- 12 Nov 2025 — SOU EXTENSION 1 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Dec 2024 — NON-FINAL ACTION E-MAILED